PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

For the period ended Dec 31, 2025. Filed Feb 25, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Feb 25, 2026

PACB$2.36+4.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.CONSOLIDATED BALANCE SHEETS

	December 31,
(In thousands, except par value)	2025	2024
Assets
Current assets
Cash and cash equivalents	$63,707	$55,370
Investments	215,799	334,561
Accounts receivable, net	35,448	27,524
Inventory, net	49,285	58,755
Prepaid expenses and other current assets	10,793	18,781
Short-term restricted cash	20	690
Total current assets	375,052	495,681
Property and equipment, net	24,146	30,505
Operating lease right-of-use assets, net	41,695	16,091
Long-term restricted cash	1,532	1,532
Intangible assets, net	15,124	389,572
Goodwill	317,761	317,761
Other long-term assets	8,773	9,305
Total assets	$784,083	$1,260,447
Liabilities and Stockholders’ Equity
Current liabilities
Accounts payable	$20,770	$16,590
Accrued expenses	33,646	22,595
Deferred revenue, current	15,936	13,864
Operating lease liabilities, current	448	10,026
Other liabilities, current	2,031	3,224
Total current liabilities	72,831	66,299
Deferred revenue, non-current	3,929	5,900
Contingent consideration liability, non-current	—	18,700
Operating lease liabilities, non-current	56,592	14,914
Convertible senior notes, net, non-current	645,382	647,494
Other liabilities, non-current	—	546
Total liabilities	778,734	753,853
Commitments and contingencies
Stockholders’ equity
Preferred stock, $0.001 par value:
Authorized 50,000 shares; No shares issued or outstanding	—	—
Common stock, $0.001 par value:
Authorized 1,000,000 shares; issued and outstanding 301,956 and 294,418 shares at December 31, 2025 and December 31, 2024, respectively	302	294
Additional paid-in capital	2,699,892	2,654,804
Accumulated other comprehensive income	457	422
Accumulated deficit	(2,695,302)	(2,148,926)
Total stockholders’ equity	5,349	506,594
Total liabilities and stockholders’ equity	$784,083	$1,260,447

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.